MedPath

MANHATTAN PSYCHIATRIC CENTER

🇺🇸United States
Ownership
-
Established
1848-01-01
Employees
-
Market Cap
-
Website

Clinical Trials

8

Active:0
Completed:6

Trial Phases

3 Phases

Phase 2:3
Phase 4:1
Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (50.0%)
Phase 2
3 (37.5%)
Phase 4
1 (12.5%)

Transcranial Direct-current Stimulation (tDCS) in Treatment Refractory Auditory Hallucinations

Not Applicable
Completed
Conditions
Auditory Hallucination
Schizophrenia
First Posted Date
2018-04-02
Last Posted Date
2018-04-04
Lead Sponsor
Manhattan Psychiatric Center
Target Recruit Count
27
Registration Number
NCT03485131
Locations
🇺🇸

Manhattan Psychiatric Center, New York, New York, United States

Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder

Phase 2
Withdrawn
Conditions
Schizophrenia
Interventions
First Posted Date
2009-02-06
Last Posted Date
2020-10-14
Lead Sponsor
Manhattan Psychiatric Center
Registration Number
NCT00838227

Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia

Not Applicable
Conditions
Chronic Schizophrenia
First Posted Date
2008-04-22
Last Posted Date
2015-04-17
Lead Sponsor
Manhattan Psychiatric Center
Target Recruit Count
142
Registration Number
NCT00664274
Locations
🇺🇸

Manhattan Psychiatric Center, Wards Island, New York, United States

Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness

Not Applicable
Completed
Conditions
Schizophrenia
Schizoaffective Disorder
Bipolar Disorder
First Posted Date
2008-04-21
Last Posted Date
2010-08-09
Lead Sponsor
Manhattan Psychiatric Center
Target Recruit Count
295
Registration Number
NCT00661869
Locations
🇺🇸

Manhattan Psychiatric Center, New York, New York, United States

Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder

Phase 4
Completed
Conditions
Schizophrenia
Schizoaffective Disorder
Interventions
First Posted Date
2007-07-16
Last Posted Date
2015-04-15
Lead Sponsor
Manhattan Psychiatric Center
Target Recruit Count
20
Registration Number
NCT00501618
Locations
🇺🇸

Manhattan Psychiatric Center, 125th Street, Out Patient Clinic, New York, New York, United States

🇺🇸

Manhattan Psychiatric Center, Inpatient Unit, New York, New York, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.